Published in Thromb Haemost on May 01, 1994
Antiplatelet drug 'resistance'. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact? Nat Rev Cardiol (2009) 0.94
Outpatient management of congestive heart failure. Tex Heart Inst J (1998) 0.77
The impact of blood shear rate on arterial thrombus formation. Future Sci OA (2015) 0.76
The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med (1989) 6.99
Plasma endotoxin as a predictor of multiple organ failure and death in systemic meningococcal disease. J Infect Dis (1989) 3.66
Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium. Nature (1979) 3.06
Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response. J Exp Med (1989) 2.68
Induction of transforming growth factor-alpha in activated human alveolar macrophages. Cell (1988) 2.13
Effect of near normoglycaemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: the Oslo study. Br Med J (Clin Res Ed) (1986) 1.83
The macrophage electrophoretic migration (MEM) test for lymphocyte sensitization. A study of the kinetics. Clin Exp Immunol (1973) 1.49
Shear-induced platelet activation and platelet microparticle formation at blood flow conditions as in arteries with a severe stenosis. Arterioscler Thromb Vasc Biol (1997) 1.46
Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3? J Thromb Haemost (2007) 1.46
A perfusion chamber developed to investigate platelet interaction in flowing blood with human vessel wall cells, their extracellular matrix, and purified components. J Lab Clin Med (1983) 1.44
Complement activation and endotoxin levels in systemic meningococcal disease. J Infect Dis (1989) 1.44
Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III. J Clin Invest (1985) 1.40
Myocardial ischaemia and the inflammatory response: release of heat shock protein 70 after myocardial infarction. Heart (2005) 1.38
Meningococcal endotoxin in lethal septic shock plasma studied by gas chromatography, mass-spectrometry, ultracentrifugation, and electron microscopy. J Clin Invest (1992) 1.35
A common tumour specific antigen. I. Restriction in vivo to malignant neoplastic tissue. Br J Cancer (1973) 1.34
Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes. J Exp Med (1996) 1.33
Effects of ticlopidine in AV-fistula surgery in uremia. Fistula Study Group. Scand J Urol Nephrol (1998) 1.30
Systemic meningococcal disease: a model infection to study acute endotoxinemia in man. Prog Clin Biol Res (1988) 1.30
Nucleotide sequence of the cDNA coding for human complement C1r. Biochemistry (1986) 1.29
Localization of encephalitogenic basic protein in the intraperiod line of lamellar myelin. Nature (1970) 1.28
Localization of tumour specific antigen on external surface of plasma membrane. Nat New Biol (1972) 1.25
Neisseria meningitidis lipopolysaccharides in human pathology. J Endotoxin Res (2001) 1.23
Red blood cell size is important for adherence of blood platelets to artery subendothelium. Blood (1983) 1.23
The role of platelet membrane glycoproteins Ib and IIb-IIIa in platelet adherence to human artery subendothelium. Br J Haematol (1986) 1.20
Deficiency of platelet membrane glycoprotein Ia associated with a decreased platelet adhesion to subendothelium: a defect in platelet spreading. Blood (1986) 1.20
Compartmentalization of lipopolysaccharide production correlates with clinical presentation in meningococcal disease. J Infect Dis (1992) 1.16
A common tumour specific antigen. II. Further characterization of the whole antigen and of a cross-reacting antigen of normal tissues. Br J Cancer (1974) 1.15
In-vitro inhibition by unsaturated fatty acids of the PPD- and PHA-induced lymphocyte response. Klin Wochenschr (1974) 1.13
Subendothelial proteins and platelet adhesion. von Willebrand factor and fibronectin, not thrombospondin, are involved in platelet adhesion to extracellular matrix of human vascular endothelial cells. Arteriosclerosis (1986) 1.12
DDAVP enhances platelet adherence and platelet aggregate growth on human artery subendothelium. Blood (1984) 1.10
Von Willebrand factor in the vessel wall mediates platelet adherence. Blood (1985) 1.09
The chemical nature of cancer basic protein. Br J Cancer Suppl (1973) 1.09
Sulfonamide and trimethoprim concentrations in human serum and skin blister fluid. Antimicrob Agents Chemother (1981) 1.08
Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res (1985) 1.05
Plasminogen activator inhibitor 1 and 2, alpha-2-antiplasmin, plasminogen, and endotoxin levels in systemic meningococcal disease. Thromb Res (1990) 1.05
Electron microscopical study of Neisseria meningitidis releasing various amounts of free endotoxin. Acta Pathol Microbiol Scand B (1979) 1.04
Phosphorylation sites in the integrin beta3 cytoplasmic domain in intact platelets. J Biol Chem (1999) 1.03
Antibody penetration into LR-White sections. Micron (1994) 1.02
Binding of factor VIII-von Willebrand factor to human arterial subendothelium precedes increased platelet adhesion and enhances platelet spreading. J Lab Clin Med (1981) 1.02
Adhesion of platelets to human artery subendothelium: effect of factor VIII-von Willebrand factor of various multimeric composition. Blood (1984) 1.01
Prognostic factors in patients with metastatic (stage D2) prostate cancer: experience from the Scandinavian Prostatic Cancer Group Study-2. J Urol (1997) 1.00
Long-term effects of n-3 polyunsaturated fatty acids on haemostatic variables and bleeding episodes in patients with coronary artery disease. Blood Coagul Fibrinolysis (1995) 0.99
Antigen cross-reactivity in the macrophage electrophoretic mobility test. A study using cellular affinity chromatography. Clin Exp Immunol (1974) 0.99
Platelet adherence to subendothelium of human arteries in pulsatile and steady flow. Thromb Res (1981) 0.99
Fish oil and plasma fibrinogen. BMJ (1988) 0.98
The quantitative association of plasma endotoxin, antithrombin, protein C, extrinsic pathway inhibitor and fibrinopeptide A in systemic meningococcal disease. Thromb Res (1989) 0.98
The excessive complement activation in fulminant meningococcal septicemia is predominantly caused by alternative pathway activation. J Infect Dis (1996) 0.98
Increased activation of coagulation and formation of late deep venous thrombosis following discontinuation of thromboprophylaxis after hip replacement surgery. Thromb Res (1995) 0.97
Repeated-dose pharmacodynamics of clopidogrel in healthy subjects. Semin Thromb Hemost (1999) 0.97
Elevated VIP and endotoxin plasma levels in human gram-negative septic shock. Regul Pept (1989) 0.97
Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lab Invest (1993) 0.95
Blood flow and antithrombotic drug effects. Am Heart J (1998) 0.95
LPS-induced release of IL-1 beta, IL-6, IL-8, TNF-alpha and sCD14 in whole blood and PBMC from persons with high or low levels of HDL-lipoprotein. Cytokine (1994) 0.94
Functional domains on von Willebrand factor. Recognition of discrete tryptic fragments by monoclonal antibodies that inhibit interaction of von Willebrand factor with platelets and with collagen. J Clin Invest (1984) 0.94
Pharmacokinetic studies of antibacterial agents using the suction blister method. Scand J Infect Dis Suppl (1990) 0.94
Cellular activating properties and morphology of membrane-bound and purified meningococcal lipopolysaccharide. J Endotoxin Res (2000) 0.94
5-aminoimidazole-4-carboxy-amide-1-beta-D-ribofuranoside treatment ameliorates hyperglycaemia and hyperinsulinaemia but not dyslipidaemia in KKAy-CETP mice. Diabetologia (2001) 0.93
Macrophage tropism: fact or fiction? J Leukoc Biol (1997) 0.93
A study of the value of resin-embedded semi-thin sections and electron microscopy in the diagnosis of renal biopsies. Acta Pathol Microbiol Scand A (1981) 0.93
Single-dose pharmacodynamics of clopidogrel. Semin Thromb Hemost (1999) 0.93
Different binding of 125I-LPS to plasma proteins from persons with high or low HDL. Scand J Clin Lab Invest (1996) 0.92
Nuclear texture analysis: a new prognostic tool in metastatic prostate cancer. Cytometry (1996) 0.92
A perfusion chamber developed to investigate thrombus formation and shear profiles in flowing native human blood at the apex of well-defined stenoses. Arterioscler Thromb (1994) 0.92
Sequential intrapulmonary and systemic activation of coagulation and fibrinolysis during and after total hip replacement surgery. Thromb Res (1993) 0.92
Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine. Clin Pharmacol Ther (1982) 0.91
DNA polymorphisms at fibrinogen loci and plasma fibrinogen concentration. Clin Genet (1989) 0.91
Collagen surfaces to measure thrombus formation under flow: possibilities for standardization. J Thromb Haemost (2011) 0.91
Collagen induced thrombus formation at the apex of eccentric stenoses--a time course study with non-anticoagulated human blood. Thromb Haemost (1996) 0.91
Molecular mechanisms in the compartmentalized inflammatory response presenting as meningococcal meningitis or septic shock. Microb Pathog (1992) 0.91
Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91
Long-term glycemic control and kidney function in insulin-dependent diabetes mellitus. Kidney Int (1992) 0.90
LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine (1996) 0.89
Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility. Ann Thorac Surg (1996) 0.89
Shear rate-dependent impairment of thrombus growth on collagen in nonanticoagulated blood from patients with von Willebrand disease and hemophilia A. Blood (1992) 0.89
Isolation of monocytes from whole blood by density gradient centrifugation and counter-current elutriation followed by cryopreservation: six years' experience. Scand J Clin Lab Invest (2000) 0.88
Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb (1994) 0.88
Acetylsalicylic acid and sodium salicylate inhibit LPS-induced NF-kappa B/c-Rel nuclear translocation, and synthesis of tissue factor (TF) and tumor necrosis factor alfa (TNF-alpha) in human monocytes. Thromb Haemost (1996) 0.88
Effects of ionic and nonionic contrast media on endothelium and on arterial thrombus formation. Acta Radiol (1996) 0.88
Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood (2001) 0.88
Drug binding in sera deficient in lipoproteins, albumin or orosomucoid. Br J Clin Pharmacol (1983) 0.88
Reduced effect of aspirin on thrombus formation at high shear and disturbed laminar blood flow. Thromb Haemost (1996) 0.87
Maple syrup urine disease. Four years' experience with dietary treatment of a case. Acta Paediatr Scand (1969) 0.87
Aetiology of multiple sclerosis. Lancet (1974) 0.87
Thrombin generation during collection and storage of blood. Vox Sang (1986) 0.87
Studies on soluble fibrin in plasma. I. N-terminal analysis of a modified fraction I (Cohn) from normal and thrombin-incubated plasma. Scand J Clin Lab Invest (1971) 0.87
Relationship between alpha 1-acid glycoprotein and plasma binding of disopyramide and mono-N-dealkyldisopyramide. Br J Clin Pharmacol (1984) 0.87
Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models. Arterioscler Thromb (1991) 0.87
Fibrinemia in medical patients screened by the ethanol test. Acta Med Scand (1971) 0.86
Bacteremia and compartmentalization of LPS in meningococcal disease. Prog Clin Biol Res (1995) 0.86
Ultrasonographic evaluation of invasive lobular carcinoma. Acta Radiol (1999) 0.86
Immunologic quantification of fibrin deposition in thrombi formed in flowing native human blood. Br J Haematol (1996) 0.86
Reduction of urinary albumin excretion after 4 years of continuous subcutaneous insulin infusion in insulin-dependent diabetes mellitus. The Oslo Study. Acta Endocrinol (Copenh) (1988) 0.85
Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/Org31540) with high affinity to antithrombin III in man. Thromb Haemost (1995) 0.85
Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future. J Thromb Haemost (2006) 0.84
Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity. Thromb Haemost (2000) 0.84